Israel starts clinical trial of plasma-derived Covid drug
12 patients are receiving Kamada’s immunoglobulin for coronavirus disease; so far, three patients were well enough to go home from the hospital.
AUGUST 13, 2020, 7:57 AM
Abigail Klein Leichman is a writer and associate editor at ISRAEL21c. Prior to moving to Israel in 2007, she was a specialty writer and copy editor at a major daily newspaper in New Jersey and has freelanced for a variety of newspapers and periodicals since 1984.
No hay comentarios:
Publicar un comentario